JP2025503607A5 - - Google Patents
Info
- Publication number
- JP2025503607A5 JP2025503607A5 JP2024540848A JP2024540848A JP2025503607A5 JP 2025503607 A5 JP2025503607 A5 JP 2025503607A5 JP 2024540848 A JP2024540848 A JP 2024540848A JP 2024540848 A JP2024540848 A JP 2024540848A JP 2025503607 A5 JP2025503607 A5 JP 2025503607A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- serpine
- disease
- pharmaceutical composition
- condition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263266444P | 2022-01-05 | 2022-01-05 | |
| US63/266,444 | 2022-01-05 | ||
| PCT/US2022/082669 WO2023133078A2 (en) | 2022-01-05 | 2022-12-30 | Serpin peptides and methods of using the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025503607A JP2025503607A (ja) | 2025-02-04 |
| JP2025503607A5 true JP2025503607A5 (enExample) | 2025-06-02 |
Family
ID=87074167
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024540848A Pending JP2025503607A (ja) | 2022-01-05 | 2022-12-30 | セルピンペプチドおよびその使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20250161419A1 (enExample) |
| EP (1) | EP4460322A4 (enExample) |
| JP (1) | JP2025503607A (enExample) |
| CN (1) | CN118804758A (enExample) |
| AU (1) | AU2022431253A1 (enExample) |
| CA (1) | CA3247129A1 (enExample) |
| IL (1) | IL314135A (enExample) |
| WO (1) | WO2023133078A2 (enExample) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113429455B (zh) * | 2015-08-28 | 2024-11-22 | 赛品制药有限责任公司 | 用于疾病治疗的方法 |
| US10821094B2 (en) * | 2016-01-13 | 2020-11-03 | Children's Hospital Medical Center | Compositions and methods for treating allergic inflammatory conditions |
| WO2019199634A1 (en) * | 2018-04-09 | 2019-10-17 | Yale University | Bifunctional small molecules to target the selective degradation of circulating proteins |
| US20240342293A1 (en) * | 2019-10-10 | 2024-10-17 | Yale University | Engineered antibodies as molecular degraders through cellular receptors |
| EP4054713A4 (en) * | 2019-11-04 | 2024-02-07 | Azitra, Inc. | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING SKIN DISEASES AND DISORDERS USING LEKTI |
| US11779630B2 (en) * | 2020-07-06 | 2023-10-10 | Serpin Pharma, Llc | Peptides and methods of using the same |
| EP4294392A4 (en) * | 2021-02-22 | 2025-06-25 | Yale University, Inc. | TARGETED BIFUNCTIONAL DEGRADING AGENTS AND METHODS OF USE THEREOF |
-
2022
- 2022-12-30 AU AU2022431253A patent/AU2022431253A1/en active Pending
- 2022-12-30 WO PCT/US2022/082669 patent/WO2023133078A2/en not_active Ceased
- 2022-12-30 US US18/726,945 patent/US20250161419A1/en active Pending
- 2022-12-30 JP JP2024540848A patent/JP2025503607A/ja active Pending
- 2022-12-30 CA CA3247129A patent/CA3247129A1/en active Pending
- 2022-12-30 EP EP22919262.0A patent/EP4460322A4/en active Pending
- 2022-12-30 CN CN202280092284.4A patent/CN118804758A/zh active Pending
- 2022-12-30 IL IL314135A patent/IL314135A/en unknown
-
2023
- 2023-07-13 US US18/148,942 patent/US20230406906A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gozes et al. | Pharmaceutical VIP: prospects and problems | |
| US11241487B2 (en) | Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7)-bioencapsulated in plant cells attenuates pulmonary hypertension, cardiac dysfunction and development of autoimmune and experimentally induced ocular disorders | |
| JP2010540654A5 (enExample) | ||
| JPH08510205A (ja) | Ｙｙペプチドのアナログとその用途 | |
| IL192046A (en) | Intact and peptide intestinal fragments and methods of use | |
| CN107106651A (zh) | 用于治疗眼病的肽和包含所述肽的用于治疗眼病的组合物 | |
| JPH10509428A (ja) | 活性依存性神経栄養因子の神経栄養ペプチド | |
| WO2010042997A1 (en) | Compositions and methods for treatment of kidney disorders | |
| JP2022506716A5 (enExample) | ||
| JP2014519526A (ja) | 抗炎症医薬製品 | |
| WO2013082535A2 (en) | Controlled-release peptide compositions and uses thereof | |
| JP7751641B2 (ja) | Ｇｌｐ－１／ｇｌｐ－２デュアルアゴニストの医薬組成物 | |
| JP7809117B2 (ja) | Ｇｌｐ－１／ｇｌｐ－２デュアルアゴニストの医薬組成物 | |
| WO2019080919A1 (zh) | 充分剂量条件下治疗乙肝病毒相关肝病的药物和方法 | |
| CN110256574B (zh) | 融合多肽及在制备抗抑郁、神经退行性疾病药物中的应用 | |
| JP2023504904A5 (enExample) | ||
| CN102037133B (zh) | 改进的β胸腺素片段 | |
| BR112019026336A2 (pt) | forma de sal de cloridrato de um peptídeo análogo da porção c-terminal de c5a e o uso da mesma, composição, método para induzir uma resposta imune contra uma infecção ou câncer, kit e composto para aumentar uma resposta imune para um agente imunogênico | |
| JP2005506276A5 (enExample) | ||
| US10881712B2 (en) | Neuroprotective agents derived from spider venom peptides | |
| JP2012529423A5 (enExample) | ||
| US8853359B2 (en) | Endokinin C/D-derived peptides | |
| JP2018522555A5 (enExample) | ||
| WO2014202834A1 (en) | Protamine in treatment of neuronal injuries | |
| KR20220044487A (ko) | 펩티드 및 포도막염의 치료에 있어서의 그의 사용 방법 |